TABLE 1.
Baseline characteristics of participants overall and grouped by antihypertensive treatment
| Antihypertensive treatment | |||
|---|---|---|---|
| Total n = 412) | Yes (n = 240) | No (n = 172) | |
| Females (n,%) | 304 (73.8) | 167 (69.6) | 137 (79.7) |
| Age (SD) | 86.9 (7.4) | 87.5 (7.2) | 85.9 (7.6) |
| Civil status (n,%) | |||
| Married | 91 (23.3) | 50 (22.1) | 41 (25.0) |
| Widow | 251 (64.4) | 153 (67.7) | 98 (59.8) |
| MMSE (SD) | |||
| Total score | 10.2 (6.9) | 11.4 (6.6) | 8.6 (7.0) |
| Severe <11 | 222 (53.9) | 116 (48.3) | 106 (61.6) |
| Moderate 12‐17 | 116 (28.2) | 74 (30.8) | 42 (24.4) |
| Mild 18‐23 | 74 (18.0) | 50 (20.8) | 24 (14.0) |
| Blood pressure mmHg (SD) | |||
| Systolic | 128 (21.5) | 127 (20.2) | 129 (23.1) |
| Diastolic | 71 (12.5) | 71 (12.6) | 72 (12.2) |
| Antihypertensive drugs (n,%) | 240 (58.3) | ||
| Diuretics | 135 (32.8) | ||
| β‐blocking | 109 (26.5) | ||
| Calcium channel blockers | 40 (9.7) | ||
| Renin angiotensin II blockers and ACE inhibitors | 95 (23.1) | ||
| NPI‐NH (IQR) | |||
| Total score | 10 (3–23) | 8.5 (2‐20) | 13 (4‐28) |
| Psychiatric cluster | 0 (0–2) | 0 (0–2) | 0 (0‐3) |
| Mood cluster | 4 (0‐12) | 2 (0‐8) | 3 (0‐12) |
| Behavior cluster | 2 (0–9) | 4 (0–10) | 6 (1‐13) |
| Euphoria | 0 (0–3) | 0 (0–0) | 0 (0‐0) |